COR (Cencora) Ending Cash Position : $3,298 Mil (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Cencora Ending Cash Position?

Cencora's Ending Cash Position for the quarter that ended in Sep. 2024 was $3,298 Mil.

Cencora's quarterly Ending Cash Position increased from Mar. 2024 ($2,285 Mil) to Jun. 2024 ($3,476 Mil) but then declined from Jun. 2024 ($3,476 Mil) to Sep. 2024 ($3,298 Mil).

Cencora's annual Ending Cash Position declined from Sep. 2022 ($3,594 Mil) to Sep. 2023 ($2,753 Mil) but then increased from Sep. 2023 ($2,753 Mil) to Sep. 2024 ($3,298 Mil).

Cencora Ending Cash Position Historical Data

The historical data trend for Cencora's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Ending Cash Position Chart

Cencora Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Ending Cash Position

Get a 7-Day Free Trial

4,597.75

3,070.13

3,593.54

2,752.89

3,297.88

Cencora Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															2,752.89	3,036.12	2,285.15	3,476.40	3,297.88

Cencora Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cencora's Ending Cash Position for the fiscal year that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2752.889	+	544.991
	=	3,298

Cencora's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3476.396	+	-178.516
	=	3,298

Cencora Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cencora's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (NYSE:COR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

COR:Mexico 0HF3:UK ABG:Germany ABG:Germany C1CO34:Brazil

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Executives

Lazarus Krikorian	officer: Senior Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Steven H Collis	officer: President & CEO	1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Silvana Battaglia	officer: Executive Vice President	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Walgreens Boots Alliance, Inc.	10 percent owner	108 WILMOT ROAD, DEERFIELD IL 60015
Gina Clark	officer: Executive Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Dermot Mark Durcan	director
Robert P. Mauch	officer: Executive Vice President	1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Elizabeth S Campbell	officer: Executive Vice President	1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Leslie E Donato	officer: EVP & Chief Strategy Officer	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Werner Baumann	director	1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lauren M Tyler	director	C/O ALLEGHANY CORPORATION, 1411 BROADWAY, 34TH FLOOR, NEW YORK NY 10018
Redonda Miller	director	303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Lorence H. Kim	director	C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Walgreens Boots Alliance Holdings Llc	10 percent owner	108 WILMOT ROAD, DEERFIELD IL 60015
Lon R Greenberg	director	460 NORTH GULPH ROAD, KING OF PRUSSIA PA 19406